Literature DB >> 31878280

Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas.

Michele Pietrafesa1, Francesca Maddalena1, Luciana Possidente2, Valentina Condelli1, Pietro Zoppoli1, Valeria Li Bergolis3, Maria Grazia Rodriquenz4, Michele Aieta4, Giulia Vita2, Franca Esposito5, Matteo Landriscina1,3.   

Abstract

Tumor Necrosis Factor Receptor-Associated Protein 1 (TRAP1) is a heat shock protein 90 (HSP90) molecular chaperone overexpressed in 60-70% human colorectal carcinomas (CRCs) and the co-upregulation of TRAP1 and associated 6-related proteins identifies metastatic CRCs with poor prognosis. Since the molecular mechanisms responsible for TRAP1 regulation are still unknown, the significance of TRAP1 gene copy number (CN) and the role of post-transductional protein modifications were addressed. TRAP1 gene aneuploidy accounted for 34.5% of cases in a cohort of 58 human CRCs and TRAP1 CN correlated with its mRNA and protein expression, suggesting that transcriptional mechanisms are responsible for TRAP1 upregulation. Furthermore, the analysis of the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium/The Cancer Genome Atlas (CPTAC/TCGA) CRC database showed that TRAP1 polysomy significantly correlates with lymph node involvement. However, a subgroup of tumors showed TRAP1 protein levels independent from its CN. Of note, a direct correlation was observed between TRAP1 protein levels and the expression of S-nitrosoglutathione reductase (GSNOR), a denitrosylase involved in the regulation of protein S-nitrosylation. Furthermore, CRC cell lines exposed to hypoxia or dichloroacetate treatment showed the downregulation of TRAP1 upon GSNOR silencing and this resulted in increased TRAP1 mono/polyubiquitination. These data suggest that transcriptional and post-transductional mechanisms account for TRAP1 expression in human CRCs and GSNOR protects TRAP1 from S-nitrosylation and consequent proteasome degradation mostly in conditions of stress.

Entities:  

Keywords:  GSNOR; S-nitrosylation; TRAP1; colorectal carcinoma; copy number variation

Mesh:

Substances:

Year:  2019        PMID: 31878280      PMCID: PMC6981705          DOI: 10.3390/ijms21010145

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  40 in total

1.  Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents.

Authors:  Matteo Landriscina; Gabriella Laudiero; Francesca Maddalena; Maria Rosaria Amoroso; Annamaria Piscazzi; Flora Cozzolino; Maria Monti; Corrado Garbi; Alberto Fersini; Piero Pucci; Franca Esposito
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

2.  Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines.

Authors:  Annamaria Piscazzi; Eleonora Costantino; Francesca Maddalena; Maria Iole Natalicchio; Assunta Maria Teresa Gerardi; Raffaele Antonetti; Mauro Cignarelli; Matteo Landriscina
Journal:  J Clin Endocrinol Metab       Date:  2012-03-22       Impact factor: 5.958

3.  TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways.

Authors:  Ilenia Agliarulo; Danilo Swann Matassa; Maria Rosaria Amoroso; Francesca Maddalena; Lorenza Sisinni; Leandra Sepe; Maria Carla Ferrari; Diana Arzeni; Rosario Avolio; Giovanni Paolella; Matteo Landriscina; Franca Esposito
Journal:  Biochim Biophys Acta       Date:  2015-06-10

Review 4.  Regulation of mitochondrial processes by protein S-nitrosylation.

Authors:  Claude A Piantadosi
Journal:  Biochim Biophys Acta       Date:  2011-03-21

5.  Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis.

Authors:  N Montesano Gesualdi; G Chirico; G Pirozzi; E Costantino; M Landriscina; F Esposito
Journal:  Stress       Date:  2007-11       Impact factor: 3.493

6.  TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins.

Authors:  M R Amoroso; D S Matassa; G Laudiero; A V Egorova; R S Polishchuk; F Maddalena; A Piscazzi; S Paladino; D Sarnataro; C Garbi; M Landriscina; F Esposito
Journal:  Cell Death Differ       Date:  2011-10-07       Impact factor: 15.828

7.  TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma.

Authors:  Francesca Maddalena; Vittorio Simeon; Giulia Vita; Annamaria Bochicchio; Luciana Possidente; Lorenza Sisinni; Giacomo Lettini; Valentina Condelli; Danilo Swann Matassa; Valeria Li Bergolis; Alberto Fersini; Sante Romito; Michele Aieta; Antonio Ambrosi; Franca Esposito; Matteo Landriscina
Journal:  Oncotarget       Date:  2017-03-28

8.  Combination of TRAP1 and ERCC1 Expression Predicts Clinical Outcomes in Metastatic Colorectal Cancer Treated with Oxaliplatin/5-Fluorouracil.

Authors:  Jae Joon Han; Sun Kyung Baek; Jae Jin Lee; Gou Young Kim; Si-Young Kim; Suk-Hwan Lee
Journal:  Cancer Res Treat       Date:  2014-01-15       Impact factor: 4.679

9.  Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.

Authors:  D S Matassa; M R Amoroso; H Lu; R Avolio; D Arzeni; C Procaccini; D Faicchia; F Maddalena; V Simeon; I Agliarulo; E Zanini; C Mazzoccoli; C Recchi; E Stronach; G Marone; H Gabra; G Matarese; M Landriscina; F Esposito
Journal:  Cell Death Differ       Date:  2016-05-20       Impact factor: 15.828

Review 10.  RUNX family: Oncogenes or tumor suppressors (Review).

Authors:  Beatriz Andrea Otálora-Otálora; Berta Henríquez; Liliana López-Kleine; Adriana Rojas
Journal:  Oncol Rep       Date:  2019-05-06       Impact factor: 3.906

View more
  2 in total

1.  TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation.

Authors:  Giacomo Lettini; Valentina Condelli; Michele Pietrafesa; Fabiana Crispo; Pietro Zoppoli; Francesca Maddalena; Ilaria Laurenzana; Alessandro Sgambato; Franca Esposito; Matteo Landriscina
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

Review 2.  The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.

Authors:  Patrycja Kłos; Siarhei A Dabravolski
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.